# GS Plastic Optics expands facility for LightDeck COVID-19 test components

GS Plastic Optics (GSPO) will expand its injection molding facility in Rochester, New York, with an 8,000-square-foot addition and new equipment, funded by a $35 million federal contract to LightDeck Diagnostics. GSPO will produce laser waveguides for LightDeck's COVID-19 antibody test platform.

- Type: Expansion
- Announced: 2021-09-22
- Where: Rochester, New York, United States
- Value: $5.00M
- Status: announced
- Capacity: 8,000-square-foot addition
- Products: laser waveguides for COVID-19 tests
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [GS Plastic Optics](https://endata.com/companies/57865.md)
- [LightDeck Diagnostics](https://endata.com/companies/57866.md) (customer)

## Sources

- [medicaldesignandoutsourcing.com](https://www.medicaldesignandoutsourcing.com/lightdeck-diagnostics-contract-gs-plastic-optics-covid-19-test-expansion/), 2021-09-22: "Their impeccable attention to detail aligns very well with our own product strategy."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.